上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1137Please respect copyright.PENANAWA22DBP7tN
1137Please respect copyright.PENANAQjkrFnGybU
上集:https://www.penana.com/article/4711251137Please respect copyright.PENANAjTVC7QqRdb
1137Please respect copyright.PENANA3U6QNelYOH
1137Please respect copyright.PENANAVj4bCutn8n
1137Please respect copyright.PENANAp1gzK0elEn
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1137Please respect copyright.PENANA8IbTj1kbnc
1137Please respect copyright.PENANAgm4Mhu2ESe
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1137Please respect copyright.PENANACaBkwJgEGo
1137Please respect copyright.PENANAOvCHY8T11r
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1137Please respect copyright.PENANAxbYK8DrVRN
1137Please respect copyright.PENANA9LDnMxOmDI
1137Please respect copyright.PENANAAinXxcoXhD
1137Please respect copyright.PENANAXNl9kczJC3
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1137Please respect copyright.PENANAkiiCozY9gN
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1137Please respect copyright.PENANAzGWu2J148v
1137Please respect copyright.PENANAO4BAlcih8I
忘記甚麼是Neoantigen的話,可重溫上一集。1137Please respect copyright.PENANAgK42NYiGhV
1137Please respect copyright.PENANA8b25cHtZWr
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1137Please respect copyright.PENANAxNssKtW9X9
1137Please respect copyright.PENANAxCtF3991a9
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1137Please respect copyright.PENANAc6tESDk4xj
1137Please respect copyright.PENANAVKNtcjE4hL
1137Please respect copyright.PENANAenvfkiaQBu
1137Please respect copyright.PENANAX9SlGysqMa
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1137Please respect copyright.PENANAF9OfgJuA3t
1137Please respect copyright.PENANA2SbO6ZaPdr
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1137Please respect copyright.PENANANpLQUDb2oS
1137Please respect copyright.PENANAYFMsBqEp1l
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1137Please respect copyright.PENANAtAIt4rjF5c
1137Please respect copyright.PENANABHezgPrNiR
1137Please respect copyright.PENANATWOgHskqDY
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1137Please respect copyright.PENANA2w5eGutICB
1137Please respect copyright.PENANADzhQHfVLAG
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1137Please respect copyright.PENANAYsj9i07mo3
1137Please respect copyright.PENANA70eqKL9xAb
1137Please respect copyright.PENANAaty2d18EXw
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1137Please respect copyright.PENANAtEUZ1NIUqt
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1137Please respect copyright.PENANAxbmbCi1pkJ
1137Please respect copyright.PENANA57bz0Awx1G
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1137Please respect copyright.PENANA2kO4VcbcVp
1137Please respect copyright.PENANAXboEsQCf2I
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1137Please respect copyright.PENANA9yvG0go5qN
1137Please respect copyright.PENANAkkQOnw1Jew
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1137Please respect copyright.PENANAp9DkkBjyeO
1137Please respect copyright.PENANAMw8OOkRiYu
1137Please respect copyright.PENANA8QpHSpsXXD
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1137Please respect copyright.PENANAXHx7tZ9SGk
1137Please respect copyright.PENANAmXiVKVXvTi
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1137Please respect copyright.PENANATFI6rAi0CC
1137Please respect copyright.PENANAdnlTdhZs33
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1137Please respect copyright.PENANAObtpXEKEQJ
1137Please respect copyright.PENANAx8rqmmmwJX
Link:1137Please respect copyright.PENANARKosSeKENr
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1137Please respect copyright.PENANAq3MLnoDUze
1137Please respect copyright.PENANAoDDxpjlhmF
1137Please respect copyright.PENANAdzs6cxiNsQ
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1137Please respect copyright.PENANAEjsWa8EQ6H
arrow_back
科普專欄–薯不揀單
more_vert
-
info_outline Info
-
toc Table of Contents
-
share Share
-
format_color_text Display Settings
-
exposure_plus_1 Recommend
-
Sponsor
-
report_problem Report
-
account_circle Login
Search stories, writers or societies
Continue ReadingClear All
What Others Are ReadingRefresh
X
Never miss what's happening on Penana!
科普專欄–薯不揀單
Author:
薯仔聞茱莉
ISSUE #31
深入淺出–以免疫治療(Immunotherapy)手段醫治癌細胞(二)
LIKES 2
READS 1133
BOOKMARKS 148
campaign
Request update 0
Sponsor
Login with Facebook
or Sign up/Login to comment or bookmark!
Click to load the next chapter
X
After each update request, the author will receive a notification!
smartphone100 → Request update
X
Sponsor again
Click to login
Login first to show your name as a sponsor.
Thank you for supporting the story! :)
Please Login first.
×
Write down what you like about the story
×
Reading Theme:
Font Size:
Line Spacing:
Paragraph Spacing:
Load the next issue automatically
Reset to default
×
People Who Like This